| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104420A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104288A1 Orally disintegrable tablet forming a viscous slurry |
| 06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
| 06/06/2001 | EP0482097B1 Surfactant compositions and methods |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1298393A Quinoline derivatives |
| 06/06/2001 | CN1297774A Extraction of effective component in Northern cordyceps producing matrix |
| 06/06/2001 | CN1066627C Throat disease curing drop and its preparation |
| 06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
| 06/05/2001 | US6242601 Heterocyclic sulfamides |
| 06/05/2001 | US6242568 Zinc finger protein derivatives and methods therefor |
| 06/05/2001 | US6242490 Use of creatine |
| 06/05/2001 | US6242473 Administering histamine |
| 06/05/2001 | US6242461 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases |
| 06/05/2001 | US6242459 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 06/05/2001 | US6242452 7-aminopyrido[2,3-D]pyrimidine derivatives |
| 06/05/2001 | US6242444 5-(2,3-dihydro-5-(4-methylpiperazin-1-ylsulfonyl)-7-benzofuryl )-1-methyl-3-propyl-6,7-dihydro-1h-pyrazolo(4,3-d)pyrimidin-7-one, for example; treatment of inter alia erectile dysfunction. |
| 06/05/2001 | US6242438 3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 06/05/2001 | US6242212 Nucleotide sequences which code a protein for the diagnosis, detection and treatment of cancer |
| 06/05/2001 | US6241969 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 06/03/2001 | CA2327385A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/03/2001 | CA2327256A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 05/31/2001 | WO2001038566A2 Screening method for candidate drugs |
| 05/31/2001 | WO2001038530A1 Use of disease-associated gene |
| 05/31/2001 | WO2001038486A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001038346A2 Short peptides to target epithelial cells |
| 05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | WO2001038320A1 Vitamin d analogues |
| 05/31/2001 | WO2001038314A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 05/31/2001 | WO2001038313A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p39 kINASE INHIBITORS |
| 05/31/2001 | WO2001038312A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001038311A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | WO2001038310A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
| 05/31/2001 | WO2001038309A1 β-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR Xa |
| 05/31/2001 | WO2001038305A2 Novel il-8 receptor antagonists |
| 05/31/2001 | WO2001037868A1 Assays and therapies for latent viral infection |
| 05/31/2001 | WO2001037865A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | WO2001037857A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | WO2001037856A1 Urotensin-ii cyclic analogs |
| 05/31/2001 | WO2001037843A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 05/31/2001 | WO2001037837A1 3,4-DIHYDRO-(1H)-QUINAZOLIN-2-ONES AND THEIR USE AS CSBP/p38 KINASE INHIBITORS |
| 05/31/2001 | WO2001037823A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 05/31/2001 | WO2001037805A1 Pharmaceutical formulations of salmeterol |
| 05/31/2001 | WO2001037780A2 Urotensin-ii analogs |
| 05/31/2001 | WO2001002571A3 An interleukin-1 receptor antagonist and uses thereof |
| 05/31/2001 | WO2000073307A3 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors |
| 05/31/2001 | WO2000071140A3 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 05/31/2001 | WO2000069472A3 Enzyme-activated anti-tumor prodrug compounds |
| 05/31/2001 | WO2000066708A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/31/2001 | WO2000047194A9 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO2000009512A3 Bipyridine manganese complexes |
| 05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
| 05/31/2001 | US20010002400 Administering an antifungal agent |
| 05/31/2001 | DE19957156A1 New amino and fluoro substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine derivatives useful in treatment of e.g. arrythmias, spasms, ischaemia, pain and neurodegenerative disorders |
| 05/31/2001 | CA2395049A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 05/31/2001 | CA2392576A1 .beta.-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa |
| 05/31/2001 | CA2392472A1 Use of disease-associated gene |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392356A1 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 05/31/2001 | CA2392225A1 Novel il-8 receptor antagonists |
| 05/31/2001 | CA2392149A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
| 05/31/2001 | CA2391499A1 Compositions and methods for treatment of allergic disorders |
| 05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/30/2001 | EP1103553A2 Substituted heterocyclic derivatives |
| 05/30/2001 | EP1102789A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 05/30/2001 | EP1102761A2 Cyclopentabenzofuran derivatives and their use |
| 05/30/2001 | EP1102750A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 05/30/2001 | EP1102746A1 Substituted phenylamidines with antithrombotic action |
| 05/30/2001 | EP1102743A1 Amide derivatives which are useful as cytokine inhibitors |
| 05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
| 05/30/2001 | EP1102585A2 USE OF CYCLOPENTABENZOFURAN-DERIVATIVES FOR COMBATING NF-$g(k)B-DEPENDENT DISEASES |
| 05/30/2001 | EP1102535A2 Compounds and methods |
| 05/30/2001 | CN1296847A Medicinal composition for treating asthma and tracheitis |
| 05/30/2001 | CN1296845A Capsule 'Feidanwang' for treating pulmonary tuberculosis |
| 05/30/2001 | CN1296841A Extract of Chinese-medicinal herbs and its application |
| 05/30/2001 | CN1296814A Medical aerosol without freon for treating diseases in respiratory system |
| 05/30/2001 | CN1066445C Aroyl-piperidine derivs. |
| 05/30/2001 | CN1066436C Cyclohexanes and cyclohexenes derivs. |
| 05/29/2001 | US6239173 Antiinflammatory, antipyretic, analgesic, and antiarthritic agents |
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/29/2001 | US6239147 To treat cns, gastrointestinal and other disorders. substance p antagonists having improved activity and fewer side effects, treatment of emesis induced by antineoplastic agents, isochroman ring |
| 05/29/2001 | US6239138 Vitronectin receptor antagonist |
| 05/29/2001 | US6239130 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 05/29/2001 | US6239116 Immunostimulatory nucleic acid molecules |
| 05/29/2001 | US6239102 Concentrate comprising, as active agent, (3'-desoxy-3-oxo-mebmc)1-(val)2-cyclosporin, stabilizer selected from oleic acid or palmitoyl oleoyl phosphatidyl glycerol or salts thereof, ethanol |
| 05/29/2001 | US6238900 Nucleotide sequence coding enzymatic polypeptide; for the prevention of bacterial infections; bactericides |
| 05/29/2001 | US6238882 Nucleotide sequence from streptococcus; diagnosis; drug screening for new bactericides; primers; probes; antibodies; vaccines |
| 05/29/2001 | US6238878 FVlla/TF activity inhibiting compounds |
| 05/29/2001 | US6238666 Polypeptide |
| 05/29/2001 | US6238647 Anticholinergic medicament which is selected from the group consisting of ipratropium, atropine, oxitropium and salts thereof |